BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35130379)

  • 1. Dermatologists are more likely than oncologists to prescribe skin-directed therapies for early-stage cutaneous T-cell lymphoma: a retrospective review.
    Lin J; Rumsey K; Stepenaskie S; Durkin JR
    Dermatol Online J; 2021 Oct; 27(10):. PubMed ID: 35130379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bexarotene gel: a new skin-directed treatment option for cutaneous T-cell lymphomas.
    Martin AG
    J Drugs Dermatol; 2003 Apr; 2(2):155-67. PubMed ID: 12852367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging and management of cutaneous T-cell lymphoma.
    Scarisbrick JJ
    Clin Exp Dermatol; 2006 Mar; 31(2):181-6. PubMed ID: 16487086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of refractory early-stage cutaneous T-cell lymphoma.
    Huber MA; Staib G; Pehamberger H; Scharffetter-Kochanek K
    Am J Clin Dermatol; 2006; 7(3):155-69. PubMed ID: 16734503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversies in the management of the cutaneous T cell lymphomas.
    Zic JA
    Dermatol Ther; 2009; 22(5):407-17. PubMed ID: 19845718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of phototherapy in cutaneous T-cell lymphoma.
    Pothiawala SZ; Baldwin BT; Cherpelis BS; Lien MH; Fenske NA
    J Drugs Dermatol; 2010 Jul; 9(7):764-72. PubMed ID: 20677530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous T-cell lymphoma in a patient with celiac disease.
    Wang CM; Nadeem S; Jahan-Tigh RR; Duvic M
    Cutis; 2016 Jul; 98(1):E1-2. PubMed ID: 27529713
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous T cell lymphoma: update on treatment.
    Wollina U
    Int J Dermatol; 2012 Sep; 51(9):1019-36. PubMed ID: 22909354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of rare cutaneous T‑cell lymphoma and blastic plasmacytoid dendritic cell neoplasm].
    Wehkamp U; Weichenthal M
    Hautarzt; 2017 Sep; 68(9):711-715. PubMed ID: 28795194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic alternatives in cutaneous T-cell lymphoma.
    Holloway KB; Flowers FP; Ramos-Caro FA
    J Am Acad Dermatol; 1992 Sep; 27(3):367-78. PubMed ID: 1383293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of cutaneous T-cell lymphomas: Established and emergent therapies.
    Wain T; Venning VL; Consuegra G; Fernandez-Peñas P; Wells J
    Australas J Dermatol; 2019 Aug; 60(3):200-208. PubMed ID: 30809800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of maintenance phototherapy in cutaneous T-cell lymphoma.
    Pothiawala SZ; Baldwin BT; Cherpelis BS; Glass LF; Fenske NA
    J Drugs Dermatol; 2010 Jul; 9(7):800-3. PubMed ID: 20677536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New and experimental skin-directed therapies for cutaneous lymphomas.
    Farkas A; Kemeny L; French LE; Dummer R
    Skin Pharmacol Physiol; 2009; 22(6):322-34. PubMed ID: 19786826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous T-cell lymphoma: overview and nursing perspectives.
    McCann SA
    Nurs Clin North Am; 2007 Sep; 42(3):421-55, vi-vii. PubMed ID: 17825663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of the primary cutaneous lymphomas.
    Prince HM; McCormack C; Ryan G; O'Keefe R; Seymour JF; Baker C
    Australas J Dermatol; 2003 Nov; 44(4):227-40; quiz 241-2. PubMed ID: 14616487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menus for managing patients with cutaneous T-cell lymphoma.
    Poligone B; Heald P
    Semin Cutan Med Surg; 2012 Mar; 31(1):25-32. PubMed ID: 22361286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic therapy of cutaneous T-cell lymphoma (CTCL).
    Alpdogan O; Kartan S; Johnson W; Sokol K; Porcu P
    Chin Clin Oncol; 2019 Feb; 8(1):10. PubMed ID: 30818958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis.
    Nevala H; Karenko L; Vakeva L; Ranki A
    Br J Dermatol; 2001 Dec; 145(6):928-37. PubMed ID: 11899146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous T-cell lymphoma/leukemia.
    Siegel RS; Kuzel TM
    Curr Treat Options Oncol; 2000 Apr; 1(1):43-50. PubMed ID: 12057060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.